Back to search

Article

Magnesium Sulphate in Neonatal Hypoxic-Ischemic Encephalopathy: Bridging the Gap Between Molecular Neuroprotection and Clinical Outcomes

2026-07-21

Abstract excerpt

Neonatal hypoxic-ischemic encephalopathy (HIE) remains one of the leading causes of neonatal mortality and long-term neurodevelopmental disability despite therapeutic hypothermia, which provides only partial neuroprotection. Among adjunctive therapies, magnesium sulphate (MgSO4) has emerged as one of the most biologically plausible neuroprotective agents because of its ability to modulate glutamate-mediated excito...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
eec27536-5e06-5753-ba18-472d1ae87dc0
DOI
10.20944/preprints202607.1491.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Magnesium Sulphate in Neonatal Hypoxic-Ischemic Encephalopathy: Bridging the Gap Between Molecular Neuroprotection and Clinical OutcomesDOI 10.20944/preprints202607.1491.v1
Select a neighboring publication to make it the new centre.